The European Commission approves AstraZeneca's Enhertu for a new breast cancer indication while also expanding Imfinzi label ...
Global financial markets experienced a significant downturn, erasing trillions in equity value due to President Trump's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback